Long Ideas - Shares of Aeterna Zentaris (NASDAQ:AEZS) are strong Thursday morning after a Buy initiation from Roth Capital with a $1.75 price target, more than double its … Continue Reading
Read NowQuick Picks - Delcath Systems (NASDAQ:DCTH) is trading with above-average volume for the second day in a row, but after gapping up 8% at the open, is giving … Continue Reading
Read NowQuick Picks - Spectrum Pharmaceuticals (NASDAQ:SPPI) moves another cancer treatment further along the pipeline on Wednesday with the initiation of a Phase III trial of Zevalin as a … Continue Reading
Read NowLong Ideas - On Tuesday morning, Navidea Biopharmaceuticals (NASDAQ:NAVB) announced that it commenced enrollment of a Phase II trial for its radiopharmaceutical agent, NAV4694, which is being tested … Continue Reading
Read NowQuick Picks - Shares of Optimer Pharmaceuticals (NASDAQ:OPTR) are off 6% from their peak earlier this month, and have fallen nearly 15% from their 52-week high, as investors … Continue Reading
Read NowMost Popular - Shares of Navidea Biopharmaceuticals (NASDAQ:NAVB) are trading up 9% Monday on optimism over a quick resubmission of information in support of Lymphoseek’ approval following a … Continue Reading
Read NowQuick Picks - Targacept (NASDAQ:TRGT) announced Monday morning that its Phase II trial for TC-5619 in the treatment of inattentive-predominant attention deficit/hyperactivity disorder (ADHDi) did not meet its … Continue Reading
Read Now